Picture Berlin Partner BIO 2024 International Convention San Diego 650x100px
Document › Details

OrbiMed Advisors LLC. (5/3/23). "Press Release: OrbiMed Expands to Europe, Opens London Office". New York, NY.

Region Region London, Greater London
  Country United Kingdom (GB)
Organisations Organisation OrbiMed Advisors LLC
  Group OrbiMed (Group)
  Organisation 2 OrbiMed, London Office
  Group OrbiMed (Group)
Products Product investment management
  Product 2 healthcare
Persons Person Gordon, Carl L. (OrbiMed Advisors 201509 Partner)
  Person 2 Weedon, Dimitrios (OrbiMed 202305– Managing Director in new London Office)

OrbiMed is excited to announce the opening of its inaugural London office, located at 22a St. James’s Square. This expansion is a logical culmination of OrbiMed’s many decades of commitment to the European life sciences industry.

“With approximately $1.5 billion currently invested in 50 public or private European companies, OrbiMed is an established leader in the European life sciences industry,” stated Managing Partner Carl Gordon. “We look forward to building on this strong foundation to provide even greater local support for our network of European portfolio companies, entrepreneurs, and limited partners.”

Matthew Rizzo, General Partner of OrbiMed said, “As part of this expansion, we will accelerate the availability of credit and financing solutions to support healthcare growth and innovation across Europe.”

OrbiMed’s European business activities include serving as the Portfolio Manager for the Worldwide Healthcare Trust PLC and the Biotech Growth Trust PLC, which currently boast more than $3 billion in combined assets under management.

Dimitrios Weedon, Managing Director, has joined OrbiMed as the initial London-based team member, focusing on structured private credit, growth equity, and royalty monetization opportunities. Further team additions are planned to focus on public and private equity investments. Dimitrios can be reached by email:

About OrbiMed

OrbiMed is a leading healthcare investment firm, with over $17 billion in assets under management. OrbiMed invests globally across the healthcare industry, from start-ups to large multinational corporations, through private equity funds, public equity funds, and royalty/credit funds. OrbiMed seeks to be a capital provider of choice, providing tailored financing solutions and extensive global team resources to help build world-class healthcare companies. OrbiMed’s team of over 100 professionals is based in New York City, London, San Francisco, Shanghai, Hong Kong, Mumbai, Herzliya, and other key global markets.


Carter Neild, CFA
Phone: (212) 739.6400

Record changed: 2024-01-20


Picture Berlin Partner Voices Robinson Data for Precision Medicine 650x200px

More documents for OrbiMed (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]


Picture Berlin Partner Top News Healthtech Company Mika 650x300px

» top